Martha M Kirstein

8PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 28, 2020
Letter: sequential or combined systemic treatment for unresectable hepatocellular carcinoma-authors' reply.

Martha M Kirstein, Bernhard Scheiner, Matthias Pinter

|Jun 22, 2020
Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma.

Leon Schönfeld, Jan B Hinrichs, Steffen Marquardt

|May 21, 2020
Sequential systemic treatment in patients with hepatocellular carcinoma.

Martha M Kirstein, Bernhard Scheiner, Tristan Marwede

|Apr 24, 2020
The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis.

Young-Seon Mederacke, Martha M Kirstein, Anika Großhennig

|Feb 05, 2019
Second-line chemotherapy in biliary tract cancer: Outcome and prognostic factors.

Nora Schweitzer, Martha M Kirstein, Anna-Maria Kratzel

|Jan 22, 2019
Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma.

Lena Schulte, Bernhard Scheiner, Torsten Voigtländer

Pageof 2